In MCAS patients, every mast cell degranulation event places acute demand on methylation, sulfation, and glucuronidation pathways simultaneously
Full protocol responses are evaluated at the 6-month mark with provider follow-up
*Names have been changed to protect privacy.
Top Benefits: Supports sustainable weight management with average losses of up to 15-17% of total body weight in clinical studies Enhances satiety and portion control Promotes balanced blood sugar and metabolic health Dual-agonist injection that activates both GLP-1 and GIP receptors for enhanced appetite regulation, glucose balance, and fat metabolism
Certain nutrients such as vitamins A, C, and E, antioxidants, and minerals may help maintain eye function, protect your eyes against harmful light, and reduce the development of age-related degenerative diseases